Safety data and patterns of progression in met diagnostic subgroups in OAM4558g; A phase II trial evaluating MetMAb in combination with erlotinib in advanced NSCLC. Article

Vashishtha, A, Patel, PH, Yu, W et al. (2011). Safety data and patterns of progression in met diagnostic subgroups in OAM4558g; A phase II trial evaluating MetMAb in combination with erlotinib in advanced NSCLC. . JOURNAL OF CLINICAL ONCOLOGY, 29(15_suppl), 7604-7604. 10.1200/jco.2011.29.15_suppl.7604

cited authors

  • Vashishtha, A; Patel, PH; Yu, W; Bothos, JG; Simpson, J; Maneatis, T; Doessegger, L; Peterson, AC; Clement-Duchene, C; Robinet, G; Krzakowski, M; Blumenschein, GR; Goldschmidt, JH; Daniel, DB; Spigel, DR

authors

publication date

  • May 20, 2011

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • Clinical Research
  • Clinical Trials and Supportive Activities

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 7604

end page

  • 7604

volume

  • 29

issue

  • 15_suppl